State Of Wisconsin Investment Board Cue Biopharma, Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$10.9 - $14.53 $431,640 - $575,388	-39,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$11.2 - $16.09 $259,839 - $373,288	-23,200 Reduced 36.94%	39,600 $483,000
Q4 2020 Feb 03, 2021	SELL	$11.12 - $16.4 $32,247 - $47,559	-2,900 Reduced 4.41%	62,800 $786,000
Q3 2020 Nov 16, 2020	BUY	$15.05 - $23.54 $453,005 - $708,554	30,100 Added 84.55%	65,700 $989,000
Q2 2020 Aug 12, 2020	BUY	$12.7 - $30.73 $60,960 - $147,504	4,800 Added 15.58%	35,600 $873,000
Q1 2020 May 06, 2020	BUY	$9.85 - $22.27 $303,380 - $685,916	30,800 New	30,800 $437,000
Q3 2019 Nov 12, 2019	SELL	$6.78 - $9.28 $166,788 - $228,287	-24,600 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.18 - $9.65 $3,590 - $4,825	500 Added 2.07%	24,600 $221,000
Q1 2019 May 13, 2019	BUY	$4.7 - $9.29 $26,320 - $52,023	5,600 Added 30.27%	24,100 $186,000
Q4 2018 Feb 11, 2019	BUY	$4.35 - $8.73 $80,475 - $161,505	18,500 New	18,500 $87,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $43.9M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.